Patents Assigned to Pfizer
  • Patent number: 4784663
    Abstract: A three-component acetabular cup assembly for receiving and releasably retaining the femoral head component of a prosthesis, said cup assembly comprising an outer metal shell, a cup-shaped inner bearing of substantially rigid plastic fixedly secured within said metal shell, and a locking ring made from the same plastic as the inner bearing; the outer surface of the bearing and the inner surface of the locking ring having cooperating configurations forming a secure but releasable latch.
    Type: Grant
    Filed: November 30, 1987
    Date of Patent: November 15, 1988
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventor: Robert V. Kenna
  • Patent number: 4784642
    Abstract: An apparatus for draining fluids, for example, from a chest or pleural cavity, includes a collection chamber for collecting fluids through an inlet port for entry of the fluids. Also included is a dry or waterless suction control chamber in fluid communication with the collection chamber for regulating the degree of vacuum imposed in the collection chamber. If desired, a seal chamber can also be provided between the dry suction control chamber and the collection chamber so as to prevent any ambient or atmospheric air from passing into the collection chamber. The suction control chamber has a first inlet which is coupled to a suction source and a second inlet communicates with the ambient. A waterless regulator is provided for regulating the degree of suction imposed in the collection chamber at a plurality of predetermined preset levels of suction. This regulator is positioned between the suction inlet and the ambient inlet.
    Type: Grant
    Filed: October 7, 1986
    Date of Patent: November 15, 1988
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventors: Frederick A. Everett, Jr., Quinton J. Farrar
  • Patent number: 4785078
    Abstract: A new sulfur-containing polypeptide antibiotic produced by the hydrolysis of thiosporamicin (CP-46,192) is useful for the improving feed utilization efficiency in poultry and swine.
    Type: Grant
    Filed: November 20, 1986
    Date of Patent: November 15, 1988
    Assignee: Pfizer Inc.
    Inventors: Eugene F. Fiese, Charles E. Moppett, Wendell W. Windisch
  • Patent number: 4782900
    Abstract: Aqueous gel-forming compositions useful for improving oil recovery from subterranean hydrocarbon-containing reservoirs are prepared by reacting an aminoalkylated polyacrylamide with an aldehyde, dialdehyde or derivative thereof in aqueous medium. These compositions are particularly effective in reducing excessive water encroachment at producer wells.
    Type: Grant
    Filed: April 24, 1987
    Date of Patent: November 8, 1988
    Assignee: Pfizer Inc.
    Inventors: Fu-Ning Fung, Raymond C. Glowaky
  • Patent number: 4783467
    Abstract: A series of novel heterocyclic-substituted 1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-(1H)-one compounds have been prepared, including their pharmaceutically acceptable salts, wherein the heterocyclic ring moiety is an optionally substituted 5- or 6-membered aromatic heterocyclic group attached to the 6-, 7-, 8- or 9-positions of the aforesaid tetrahydroquinaxolinone ring. These particular compounds are useful in therapy as highly potent inotropic and therefore, are of value in the treatment of various cardiac conditions. Preferred member compounds include 7-(2,4-dimethylimidaxol-1-yl)-9-methyl-1,2,4,5,-tetrahydroimidazo (2,1-b)quinazolin-2-(1H)-one, 3,9-dimethyl-7-(2,4-dimethylimidazol-1-yl) -1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-(1H)-one and 9-methyl-7 -(1,2,4-triazol-4-yl)-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-(1H)-on e, respectively. Methods for preparing these compounds from known starting materials are provided.
    Type: Grant
    Filed: May 22, 1986
    Date of Patent: November 8, 1988
    Assignee: Pfizer Inc.
    Inventors: Simon F. Campbell, David A. Roberts
  • Patent number: 4782145
    Abstract: An efficient process for converting readily available 4-acetoxy-2-azetidinones to allyl 2-thioxopenam-3-carboxylates, intermediates useful for the synthesis of penem antibiotics.
    Type: Grant
    Filed: June 2, 1986
    Date of Patent: November 1, 1988
    Assignee: Pfizer Inc.
    Inventors: Katherine E. Brighty, David L. Lindner
  • Patent number: 4781293
    Abstract: A dressing delivery system comprising an adhesive-coated dressing, a release liner and a package are arranged such that the package acts as the means for applying the dressing to a skin area, with the opening of the package and the application of the dressing being accomplished in a single step. A simple method of preparing the dressing delivery system is also described.
    Type: Grant
    Filed: December 23, 1987
    Date of Patent: November 1, 1988
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventor: Owen L. Johns
  • Patent number: 4782165
    Abstract: In the synthesis of biotin and decarboxybiotin, a more direct method for the conversion of 1,3-diacyl-4-(bromomethyl)-5-[(5-alkoxycarbonylpentanoyl) or hexanoyl]-4-imidazolin-2-ones to 1,3-diacyl-4-[(4-alkoxybutanoyl) or pentanoyl]-1H,3H-thieno (3,4-b)imidazol-2-one via the Bunte salt of the formula ##STR1## wherein R is (C.sub.1 -C.sub.5)alkanoyl or (C.sub.2 -C.sub.5) alkoxycarbonyl, X is methyl or (C.sub.2 -C.sub.5)alkoxycarbonyl an Y is an alkali metal.
    Type: Grant
    Filed: October 1, 1987
    Date of Patent: November 1, 1988
    Assignee: Pfizer Inc.
    Inventor: Constantine Sklavounos
  • Patent number: 4782050
    Abstract: Antibacterial penicillins of the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sup.1 is a heterocyclic group and R is hydrogen, the residue of certian carboxy protecting groups or the residue of an ester group readily hydrolyzable in vivo having activity against resistant organisms.
    Type: Grant
    Filed: December 4, 1987
    Date of Patent: November 1, 1988
    Assignee: Pfizer Inc.
    Inventor: Yuhpyng L. Chen
  • Patent number: 4782146
    Abstract: A process for the synthesis of penems from azetidinones via 1-aza-4,5-dithiabicyclo[4.2.0]oct-2-en-8-one-2-carboxylate esters.
    Type: Grant
    Filed: June 16, 1987
    Date of Patent: November 1, 1988
    Assignee: Pfizer Inc.
    Inventor: Katherine E. Brighty
  • Patent number: 4778469
    Abstract: A method of producing a site for tissue ingrowth on a surgical implant by embedding a space occupier possessing a desired pattern in the surface of the implant at the desired location for ingrowth and then solubilizing the embedded space occupier to leave the pattern on the implant surface. Preferably, the implant is fabricated from a composite comprising a semi-crystalline thermoplastic resin such as polyetheretherketone or polyphenylene sulfide, and the space occupier is an acid-soluble metal plate machined to produce the desired pattern and removed by aqueous acid solution.
    Type: Grant
    Filed: November 4, 1986
    Date of Patent: October 18, 1988
    Assignee: Pfizer Hospital Products Group Inc.
    Inventors: Ruey Y. Lin, Casper F. Stark
  • Patent number: 4777288
    Abstract: A novel three-step process for preparing 4-(3,4-dichlorophenyl)-4-phenylbutanoic acid is disclosed, which involves (1) reducing 4-(3,4-dichlorophenyl)-4-ketobutanoic acid to 4-(3,4-dichlorophenyl)-4-hydroxybutanoic acid; (2) then converting the intermediate hydroxy acid formed in the first step to 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone, and (3) thereafter reacting the resulting gamma-butyrolactone compound with benzene in a Friedel-Crafts type reaction to form the desired final product. The latter compound is known to be useful as an intermediate leading to cis-(1S)(4S)- -N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine (sertraline), which is known to be a preferred anti-depressant agent in the field of medicinal chemistry. The aforementioned 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone and 4-(3,4-dichlorophenyl)-4-hydroxybutanoic acid are both novel compounds.
    Type: Grant
    Filed: June 11, 1987
    Date of Patent: October 11, 1988
    Assignee: Pfizer Inc.
    Inventors: George J. Quallich, Michael T. Williams
  • Patent number: 4776330
    Abstract: A modular femoral internal implant system for use in the treatment of femoral disorders resulting from injury, disease or congenital defect includes at least three interconnectable components: (1) an elongated epiphyseal/metaphyseal implant, (2) an intramedullary rod and (3) an angled side plate having an elongated plate portion adapted to be secured to the outer cortical wall and a hollow sleeve adapted to extend into the femur. The epiphyseal/metaphyseal implant can be connected to either the angled side plate or the intramedullary rod. The system may also include an elongated bone plate connectable to the angled side plate, one or more additional epiphyseal/metaphyseal implants of variable length, an additional angled side plate, a distal buttress plate connectable to the elongated bone plate, and a plurality of bone screws of a universal design. Preferably, many or all of the components of the system are made of an inert, resilient titanium-base alloy.
    Type: Grant
    Filed: June 23, 1986
    Date of Patent: October 11, 1988
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventors: Michael W. Chapman, Charles C. Edwards, Dana C. Mears
  • Patent number: 4777270
    Abstract: A series of novel, macrocyclic polyether compounds. The macrocycles have a 21-membered ring, containing six oxygen atoms, and they have a carboxy group (or a salt thereof) directed towards the interior of the ring. Administration of the compounds of the invention to ruminant animals (e.g. cattle and sheep) modifies their digestive fermentation processes such that the volatile fatty acids produced in the rumen contain a higher proportion of propionates rather than acetates, thereby increasing the efficiency of feed utilization in said ruminant animals. Additionally, the compounds of the invention show antibacterial activity in vitro against certain gram-positive microorganisms.
    Type: Grant
    Filed: September 4, 1986
    Date of Patent: October 11, 1988
    Assignee: Pfizer Inc.
    Inventor: Frank J. Urban
  • Patent number: 4775668
    Abstract: Antibacterial compounds have the formula ##STR1## wherein R.sup.1 is hydrogen, a pharmaceutically aceptable cation, or alkyl; A is CH, CF, CCl or N; Y is alkyl, haloalkyl, cyclopropyl, vinyl, methoxy, N-methylamino, p-fluorophenyl, p-hydroxyphenyl or p-aminophenyl; or A is carbon and is taken together with Y and the carbon and nitrogen to which A and Y are attached to form a five to seven membered ring which is optionally substituted; and R.sup.2 is a bridged-diazabicycloalkyl group.
    Type: Grant
    Filed: August 19, 1986
    Date of Patent: October 4, 1988
    Assignee: Pfizer Inc.
    Inventors: Martin R. Jefson, Paul R. McGuirk
  • Patent number: 4772717
    Abstract: A novel process is described for preparation of biotin comprising preparation of substituted 3H, 5H-imidazo[1,5c]tetrahydro thiazoles by contacting the boron trifluoride adduct of an appropriate thiazoline with the metallic derivative of an ester enolate, reducing the ester, hydrolyzing the thiazolidine moiety and hydrolyzing or oxidizing the resultant compound. Intermediates obtained in the preparation of biotin by the above process and alternate procedures for preparing said intermediates are also presented. A novel process for preparation of d-biotin is also given.
    Type: Grant
    Filed: November 16, 1987
    Date of Patent: September 20, 1988
    Assignee: Pfizer Inc.
    Inventor: Robert A. Volkmann
  • Patent number: 4771788
    Abstract: An invasive, fluid velocity measuring wire guide particularly adapted and of a size (less than 0.030 inch) for subselective placement in the coronary arterial tree, which includes a Doppler mechanism for determining the blood flow velocity in the region of the distal end of the wire guide. Although the wire guide is particularly adapted for diagnosing coronary arterial disease subselectively; it is of such a size and manipulability to be useful in other blood flow and biological fluid flow analyses. Preferably, the wire guide if flexible and steerable for precise placement. The wire guide includes an elongated wire member having a Doppler crystal attached in longitudinal alignment at its distal end. Electrical leads extend from the Doppler crystal along the wire member to the appropriate test equipment for measuring the fluid flow velocity in the region of the Doppler crystal.
    Type: Grant
    Filed: August 3, 1987
    Date of Patent: September 20, 1988
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventor: Huntly D. Millar
  • Patent number: 4772641
    Abstract: Aqueous gel-forming compositions are prepared by reacting for 1-10 hours at 50.degree.-95.degree. C., melamine, formaldehyde and a sulfurous acid salt with the optional addition of a gel-modifying agent and/or a gelling agent which is added to the composition immediately prior to use.
    Type: Grant
    Filed: June 20, 1985
    Date of Patent: September 20, 1988
    Assignee: Pfizer Inc.
    Inventors: Clifford N. Meltz, Gordon D. Gruetzmacher, Ping W. Chang
  • Patent number: 4772597
    Abstract: Certain 2-azacycloalkylthio-2-penem-3-carboxylic acid compounds are useful as antibacterials for treating mammals and have the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein: R is ##STR2## A is alkylene having 2-4 carbon atoms, alkylene having 2-4 carbon atoms wherein a carbon atom has an oxo substituent or alkylene having 2-4 carbon atoms wherein a methylene is replaced by oxygen, S(O).sub.m, or N--R.sub.3 ;B is carbonyl, thiocarbonyl, methylene or imine;R.sub.1 is hydrogen or forms an ester group which is hydroyzed in vivo;R.sub.2 is hydrogen, formyl, alkylcarbonyl, N-alkylaminocarbonyl, N-alkylaminosulfonyl, aminosulfonyl, aminocarbonyl, alkoxycarbonyl having 2-5 carbon atoms, alkylsulfonyl, alkyl, or alkyl substituted by aminocarbonyl, alkyl--S(O).sub.m --, hydroxyl, amino, alkylcarbonylamino, formamido or alkylsulfonylamino, wherein each alkyl has 1-4 carbon atoms;R.sub.
    Type: Grant
    Filed: September 13, 1984
    Date of Patent: September 20, 1988
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4769232
    Abstract: Solutions of indolmycin in a pharmaceutically-acceptable solvent are of special value in the treatment of susceptible bacterial infections in mammals, particularly swine.
    Type: Grant
    Filed: September 18, 1987
    Date of Patent: September 6, 1988
    Assignee: Pfizer Inc.
    Inventors: Larry R. Chappel, Jay J. Rash